Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed Leads Multi-Group Endorsement Of Vendor Credentialing Standards

This article was originally published in The Pink Sheet Daily

Executive Summary

AdvaMed hopes a proposal it released last week with 10 other health care groups will advance a dialogue to promote national harmonization for credentialing company sales representatives to work within clinical settings.

You may also be interested in...



Device Reps Should Limit Their Role In The Operating Room, Says Surgeon

Device company representatives have a legitimate role in the surgical suite, but many overstep, according to surgeons speaking at a meeting in Washington, D.C., Dec. 3

Industry Seeks Standards To Soothe Sales Rep Credentialing Headache

Over the last 18 to 24 months, device sales representatives say that a growing number of hospitals have begun to ask them for extensive documentation of their credentials in order to access the facilities

CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously

Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel